Department of Clinical Medicine

• E-pub ahead of print

  Treatment of intraventricular hemorrhage with external ventricular drainage and fibrinolysis. A comprehensive systematic review and meta-analysis of complications and outcome

  Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avis › Review › Forskning › peer review

• Udgivet

  Study protocol for ACTIVE study: safety and feasibility evaluation of external ventricular drainage with ACTIVE fluid exchange in intraventricular hemorrhage—a phase 2, multi-center, randomized controlled trial

  Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avis › Tidsskriftartikel › Forskning › peer review

• Udgivet

  ACTIVE study–use of active fluid exchange to treat intraventricular hemorrhage, preliminary data from a multi center, randomized controlled trial: Background: Intraventricular hemorrhage (IVH) is associated with very poor prognosis. Therapy directed at ameliorating the intraventricular clot has been limited. Although ventriculostomy is effective in controlling intracranial pressure (ICP), this technique does little to reduce morbidity or reduce the secondary inflammatory process. Occlusion rates of passive external ventricular drains (EVD) s are found to be 41%. Shunt dependency is seen in 24% of the cases and intraventricular infections are seen in 19% of patients treated with standard passive EVD. This current phase 2 safety/feasibility study evaluates the IRRAflow system, which is designed for active intracranial CSF lavage. We present the trial design and preliminary case series from the ACTIVE study–use active fluid exchange to treat intraventricular hemorrhage.

  Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avis › Konferenceartikel › Forskning › peer review

Vis alle (58) »

• OptimalTTF-1: Open-label Phase 1 clinical trial Testing Individualized skull-remodeling surgery to MAximize Levels of TTFields intensity in recurrent glioblastoma. Final analysis.

  Aktivitet: Tale eller præsentation - typer › Foredrag og mundtlige bidrag

• Open-label phase 1 clinical trial for recurrent glioblastoma testing skull-remodeling surgery to maximize TTFields intensity. Interim analysis and safety assessment of the OptimalTTF-1 trial

  Aktivitet: Tale eller præsentation - typer › Foredrag og mundtlige bidrag

Vis alle (2) »

• Collaboration with Aarhus University Hospital, Scandinavian Leader in Neurosurgery (news.cision.com)

  Presse/medie

Vis alle (1) »